Envoy Medical (COCH) has pioneered one-of-a-kind fully implanted devices for those suffering from hearing loss-Member of Audit Committee-Member of Compensation Committee

Strategic Leadership: Led a department responsible for educating physicians, fellows and clinicians in implanting neurostimulators for chronic pain and deep brain stimulation. Conducted over 200 events touching 2000 clinicians yearly. Post key product launch, converted 80% of participants to product usage. Represented Boston Scientific with all major societies and have developed relationships with leaders and societies in Pain and Neurosurgery. Creative Innovation: Collaborated with Israeli company to develop and introduce first mobile spinal cord simulator. Provided BSC with a differentiator and simulator now used in over 150 US trainings yearly and in 10 countries worldwide. Comprehensive Crisis Management: Led company readiness and response on negative AP/ICIJ story coming out on stimulators. Story coordinated by over 100 reporters, worldwide to be aired on TV, major newspapers, and Internet. Prepared worldwide BSC responses via web, physician/patient letters, sales response, FAQs, patient stories, executive media training. Internal Entrepreneur: Championed developing a patient-facing app for managing patient trials in 2012-2013. Led the development/regulatory/quality teams to engage and first patient-facing app for Boston Scientific. Program led to BSC having a digital venture team and developing apps for chronic pain, atrial fibrillation, and endovascular teams.

Start-up Leadership: Introduced the first rechargeable neurostimulator in a market that had been non-rechargeable for 20 yrs. Overcame obstacles of price point, patient use case and relationships to have rechargeable become 80% of market in 3 years. Built team of over 40 individuals driving product marketing, market development, marketing communication and strategy. Grew organization from $6 M to over $350M in revenues and from 2% market share to market leaders with over 30% market share. Out-of-the-box Market Development: Led innovative market development programs to both bring brand awareness and grow market for company. Introduced Raceagainstpain.com and Controlyourpain.com programs. In Raceagainstpain program, sponsored a Formula 3 car driven by amputated BSC pain patient in race events across country reaching thousands of pain patients. Program gained access for Boston Scientific patient to present to Congress on opioids, and led ability to drive legislative initiatives by government affairs office. Market Oriented Clinical Leadership: Worked closely with clinical affairs to define pain studies, develop protocols, identify sites and execute studies. Identified key end points and data requirements to demonstrate therapy/product advantages. Developed conference and podium strategy to maximize data exposure. For over 5 years, had largest number abstracts and talks of all competitors at major conferences. Developed materials and trained field reps on types of clinical data, refuting competitive claims and showcasing BSC.Bold R&D Leadership: Collaborated with R&D team to define a 32-channel stimulator, first in class. Considered a risky move that propelled company from 2nd place in market share to market leadership. Drove R&D to make a connector that compared competitive stimulation to BSC stimulation in patient trials. First of kind product that showcased BSC differentiation and led to conversion to BSC systems.

Acquisitions Championed the acquisition of a $300M of a novel ablation company. Led the due diligence, negotiations, investment banking management, and integration of the company. Venture investments: Led investments and strategy for Cardiac business. Conducted due diligence and term sheet development

Minimally Invasive CABG: Developed the endoscopic saphenous vein market from $10M to $150M. Led saphenous vein harvesting franchise to become gold standard in CABG surgery. Product used in 80% of surgeries from . Drove the introduction of a novel cardiac products to stabilize and lift the heart.